Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

The full GBS Patient Registry Report is available here.You can watch recordings of this year's State of the Science meetings here. For more information, please visit www.gbs-cidp.org or contact ...

CONSHOHOCKEN, Pa., Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today released new survey data illustrating how people with Guillain-Barré Syndrome experience this life ...

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...

CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with ...

In lieu of flowers, donations may be made to the Guillain-Barre Syndrome at the GBS/CIDP Foundation International, 375 East Elm Street, Suite 101, Conshohocken, PA 19428. May his memory be a blessing.

One type, the immune-mediated demyelinating neuropathies, includes Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barré syndrome (GBS) are immune-mediated neuropathies. Their pathogenesis involves an immune response to non-protein antigens, ...

“We have seen patients where they don’t know what the trigger was, but most often you typically hear about the preceding infection of some kind,” said Donna Hartlem, the executive director of GBS/CIDP ...